Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rank in Stocks #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Share Price
$8.92
Last synced: 2024-10-18
Market Cap
$674.03M
Change (1 day)
-5.14%
Change (1 year)
0.00%
Country
KR
Trade Jeisys Medical Inc. (287410)

Category

P/E ratio for Jeisys Medical Inc. (287410)
P/E ratio as of August 2026 TTM: 39.33
According to Jeisys Medical Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.33. At the end of 2022 the company had a P/E ratio of 22.83.
P/E ratio history for Jeisys Medical Inc. from 2019 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 39.33 22.52%
2023 32.10 40.59%
2022 22.83 -42.69%
2021 39.85 1.46%
2020 39.27 0.00%
2019 0.00 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
35.77 -9.04%
US
34.86 -11.36%
US
21.39 -45.62%
IE
20.90 -46.86%
US
- -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.